GALWAY, IRELAND--February 5, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.K. pharmaceutical company AstraZeneca is planning to invest $500 million over five years in its French research and manufacturing operations.

Within this article: Details investment plans for France over five years, financial performance, sale of drug lines